Is Compounded Semaglutide the Same as Wegovy?

Last reviewed: June 12, 2026

Last updated: June 12, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Both compounded semaglutide and Wegovy work by activating GLP-1 receptors in the brain to reduce hunger and slow stomach emptying, supporting weight loss in adults with obesity. However, these medications have distinct differences in manufacturing, availability, and cost that matter for your treatment decision. Understanding these distinctions helps you choose the option that fits your health needs and budget.

What Makes Compounded Semaglutide Different From Wegovy

Wegovy is a brand-name injectable semaglutide manufactured by Novo Nordisk under FDA approval, produced in large-scale facilities following strict standardized protocols. Compounded semaglutide is prepared by licensed 503A compounding pharmacies that custom-prepare the medication according to a prescription written by your healthcare provider. Both formulations contain identical semaglutide molecules, but compounding allows for personalized dosing flexibility and preparation tailored to individual patient needs without rigid pre-set dosing schedules.

The manufacturing process differs between the two products. Wegovy undergoes centralized FDA oversight with pre-filled pens containing fixed doses at 0.25 mg, 0.5 mg, 1 mg, and 2.4 mg increments. Compounded semaglutide from PlexusDx is prepared fresh by licensed pharmacies and can be customized to your specific dose requirements, allowing your provider to adjust amounts based on your response and tolerance. This flexibility means your treatment plan can evolve without waiting for different pen strengths to become available.

Cost Comparison: Compounded Semaglutide vs Wegovy Pricing

Wegovy typically costs between $900 and $1,300 per month if paying out-of-pocket, with insurance coverage varying widely depending on your plan and whether your provider documents medical necessity. PlexusDx compounded semaglutide injection is $189/mo month-to-month (or $149/mo on the 6-month plan), with pricing that remains flat regardless of your dose adjustments—your dose may need to go up, but your price won't. This pricing transparency eliminates surprise cost increases as your provider optimizes your treatment, making long-term weight loss therapy financially predictable.

Insurance eligibility presents another cost distinction. Wegovy often requires insurance pre-approval, and many plans categorize weight loss medications as non-essential, limiting coverage. PlexusDx medications work with HSA and FSA accounts, and no membership fee or insurance requirement applies. You can begin treatment immediately without waiting for insurance authorization, paying a consistent monthly rate whether you're on your starting dose or a higher therapeutic dose after several weeks of treatment.

Availability and Access: How PlexusDx Compounded Semaglutide Reaches You

Wegovy availability depends on pharmacy stock, insurance authorization timelines, and supply chain factors that can delay treatment initiation by weeks or months. PlexusDx compounded semaglutide is available across all 50 states through licensed 503A compounding pharmacies, with no insurance barrier or membership fee requirement. Your healthcare provider submits a prescription, and the compounding pharmacy prepares your personalized medication and ships it directly to your home, typically within days rather than weeks.

Geographic location no longer limits access to semaglutide therapy when using PlexusDx. Rural patients and those without nearby specialty pharmacies can receive the same clinical-grade compounded medication through mail delivery. PlexusDx accepts payment through HSA and FSA accounts, making the medication accessible even for uninsured patients or those with high-deductible insurance plans. This nationwide availability model removes traditional barriers that have prevented millions of people from accessing proven weight loss therapy.

Personalization and Genetic Testing for Optimal Semaglutide Response

The PlexusDx Precision Peptide Genetic Test analyzes GIPR (rs1800437) and MC4R (rs17782313) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

The genetic test helps your PlexusDx provider personalize your starting dose, titration schedule, and medication selection before beginning treatment. If genetic markers suggest you're a responder to GLP-1 therapy, your provider can confidently optimize dosing for faster results. If testing reveals a suboptimal genetic profile for semaglutide alone, PlexusDx offers alternative compounds like tirzepatide that target additional pathways. Adding the Precision Peptide Genetic Test at $298 provides data-driven guidance that Wegovy prescribing cannot offer, potentially accelerating your weight loss journey by matching medication to your biology.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Is compounded semaglutide from PlexusDx as safe as Wegovy?

Both compounded semaglutide and Wegovy contain identical semaglutide molecules and work through the same biological mechanism. PlexusDx compounded medications come from licensed 503A compounding pharmacies that meet rigorous quality and sterility standards. Safety profiles are equivalent, and your PlexusDx provider monitors your response just as a traditional doctor would with Wegovy, adjusting your dose based on your individual tolerance and results.

Can I switch from Wegovy to PlexusDx compounded semaglutide?

Yes, you can transition from Wegovy to PlexusDx compounded semaglutide. The active ingredient is identical, so your dose can carry over directly. Your new PlexusDx provider will review your current Wegovy dose and response, then create a treatment plan using compounded semaglutide at a flat monthly rate. Many patients switch to save significant money while maintaining the same clinical benefit and dose flexibility.

How much will I save with PlexusDx compared to Wegovy?

PlexusDx compounded semaglutide injection is $189/mo month-to-month (or $149/mo on the 6-month plan) compared to Wegovy's typical $900–$1,300 out-of-pocket cost. Over one year, PlexusDx patients save between $8,000 and $13,800 while receiving the same medication. Savings grow larger if Wegovy insurance coverage denies, which happens frequently, since PlexusDx requires no insurance or membership fee to access treatment.

What side effects does compounded semaglutide have?

Compounded semaglutide side effects mirror Wegovy's profile because they contain identical active ingredient. Common effects include nausea, vomiting, diarrhea, and constipation during dose escalation, typically resolving as your body adjusts. Serious side effects are rare when prescribed appropriately and monitored by your healthcare provider. Your PlexusDx provider adjusts your dose if side effects become uncomfortable, a flexibility that helps many patients tolerate treatment better than with fixed Wegovy pen doses.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

No — the Precision Peptide Genetic Test does not predict your response to tirzepatide or any specific medication. It analyzes pathway-level variants (GIPR (rs1800437)) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Compounded Semaglutide 2
• Is Semaglutide The Same As Ozempic
• Compounded Semaglutide
• Medvi Semaglutide

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.